Matches in SemOpenAlex for { <https://semopenalex.org/work/W2385690089> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2385690089 abstract "Objective To observe the efficacy of tiopronin combined with rosiglitazone on non-alcoholic fatty liver disease(NAFLD) and its influence on regulatory T cells. Methods A total of 100 patients with NAFLD were randomly divided into treatment group and control group with 50 cases in each. The treatment group were treated with tiopronin200 mg Bid and rosiglitazone 2 mg Bid. The control group were treated with liver-protecting tablet 1.5 g Tid. The efficacy,liver function, blood fat, insulin resistance index(HOMA-IR) and regulatory T cells were observed at 3 months after treatment. Results The levels of serum alanine aminotransferase and aspartate aminotransferase of two groups were significantly lower than those pre-treatment(t=31.81,17.94,20.31,14.86,P0.05). After treatment, the levels of serum triglycerides, total cholesterol, low-density lipoprotein cholesterol and HOMA-IR in treatment group were significantly decreased, and high-density lipoprotein cholesterol levels were significantly increased, the differences were statistically significant(t=6.84,8.81,7.59,7.41,P0.05) while only serum TG and TC in the control group was significantly decrease(t=4.71,4.96,P0.05). After treatment, the fatty liver degree of type-B ultrasonic in treatment group was significantly lower than that in control group(Z=2.56,P0.05). The total efficiency of the treatment group(92.00%) was significantly higher than that of the control group(67.10%), the difference was statistically significant(χ2=10.07,P0.05). Compared with control group, the CD4+CD25+/CD4+ratio and CD4+CD25+Foxp3/CD4+ratio were significantly increased in the treatment group, the differences were statistically significant(t=4.78,6.74,P0.05). Conclusion The effect of tiopronin combined with rosiglitazone on NAFLD has notable curative in reducing blood lipit and insulin resistance and improving liver function." @default.
- W2385690089 created "2016-06-24" @default.
- W2385690089 creator A5069609581 @default.
- W2385690089 date "2014-01-01" @default.
- W2385690089 modified "2023-09-27" @default.
- W2385690089 title "Effect of tiopronin combined with rosiglitazone on non-alcoholic fatty liver disease" @default.
- W2385690089 hasPublicationYear "2014" @default.
- W2385690089 type Work @default.
- W2385690089 sameAs 2385690089 @default.
- W2385690089 citedByCount "0" @default.
- W2385690089 crossrefType "journal-article" @default.
- W2385690089 hasAuthorship W2385690089A5069609581 @default.
- W2385690089 hasConcept C126322002 @default.
- W2385690089 hasConcept C134018914 @default.
- W2385690089 hasConcept C139572402 @default.
- W2385690089 hasConcept C2777391703 @default.
- W2385690089 hasConcept C2777700935 @default.
- W2385690089 hasConcept C2778163477 @default.
- W2385690089 hasConcept C2778772119 @default.
- W2385690089 hasConcept C2779134260 @default.
- W2385690089 hasConcept C2779306644 @default.
- W2385690089 hasConcept C2780152017 @default.
- W2385690089 hasConcept C2780541478 @default.
- W2385690089 hasConcept C2992208098 @default.
- W2385690089 hasConcept C2993741276 @default.
- W2385690089 hasConcept C71924100 @default.
- W2385690089 hasConcept C90924648 @default.
- W2385690089 hasConceptScore W2385690089C126322002 @default.
- W2385690089 hasConceptScore W2385690089C134018914 @default.
- W2385690089 hasConceptScore W2385690089C139572402 @default.
- W2385690089 hasConceptScore W2385690089C2777391703 @default.
- W2385690089 hasConceptScore W2385690089C2777700935 @default.
- W2385690089 hasConceptScore W2385690089C2778163477 @default.
- W2385690089 hasConceptScore W2385690089C2778772119 @default.
- W2385690089 hasConceptScore W2385690089C2779134260 @default.
- W2385690089 hasConceptScore W2385690089C2779306644 @default.
- W2385690089 hasConceptScore W2385690089C2780152017 @default.
- W2385690089 hasConceptScore W2385690089C2780541478 @default.
- W2385690089 hasConceptScore W2385690089C2992208098 @default.
- W2385690089 hasConceptScore W2385690089C2993741276 @default.
- W2385690089 hasConceptScore W2385690089C71924100 @default.
- W2385690089 hasConceptScore W2385690089C90924648 @default.
- W2385690089 hasLocation W23856900891 @default.
- W2385690089 hasOpenAccess W2385690089 @default.
- W2385690089 hasPrimaryLocation W23856900891 @default.
- W2385690089 hasRelatedWork W2350944681 @default.
- W2385690089 hasRelatedWork W2354292170 @default.
- W2385690089 hasRelatedWork W2361575046 @default.
- W2385690089 hasRelatedWork W2364313969 @default.
- W2385690089 hasRelatedWork W2371509828 @default.
- W2385690089 hasRelatedWork W2372429112 @default.
- W2385690089 hasRelatedWork W2383134940 @default.
- W2385690089 hasRelatedWork W2387375371 @default.
- W2385690089 hasRelatedWork W2390127860 @default.
- W2385690089 hasRelatedWork W2390748164 @default.
- W2385690089 hasRelatedWork W2391181777 @default.
- W2385690089 hasRelatedWork W2883686903 @default.
- W2385690089 hasRelatedWork W2900421891 @default.
- W2385690089 hasRelatedWork W2977901585 @default.
- W2385690089 hasRelatedWork W2982065570 @default.
- W2385690089 hasRelatedWork W3028608466 @default.
- W2385690089 hasRelatedWork W3029124575 @default.
- W2385690089 hasRelatedWork W3029571575 @default.
- W2385690089 hasRelatedWork W3032606346 @default.
- W2385690089 hasRelatedWork W66997070 @default.
- W2385690089 isParatext "false" @default.
- W2385690089 isRetracted "false" @default.
- W2385690089 magId "2385690089" @default.
- W2385690089 workType "article" @default.